Atlas Trials

Evaluation of Immune Response Against Human Papillomavirus (HPV)in Patients With Metastatic Cancer of the Anal Canal

Clinical trial NCT01845779 · COMPLETED

Trial details

NCT number
NCT01845779
Sponsor
Centre Hospitalier Universitaire de Besancon
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Metastatic Anal Canal CancerHuman Papillomavirus
Start date
2012-09-01
Primary completion
2019-07-01
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.